Analysis of paradoxical observations on the association between leptin and insulin resistance

FASEB Journal

Volumn 16, Issue 10, 2002, Pages 1163-1176

  Ceddia, Rolando B ^a   Koistinen, Heikki A ^b   Zierath, Juleen R ^c   Sweeney, Gary ^a  

^a YORK UNIVERSITY   (Canada)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Diabetes mellitus; Glucose metabolism; Lipoatrophy; Lipodystrophy; Obesity

Indexed keywords

INSULIN; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BODY FAT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONE ACTION; INSULIN RELEASE; INSULIN RESISTANCE; LIPOATROPHY; LIPODYSTROPHY; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPODYSTROPHY; LIVER; MICE; MUSCLE, SKELETAL; OBESITY; RATS; SIGNAL TRANSDUCTION;

ANIMALIA; RODENTIA;

EID: 0036328381     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0158rev     Document Type: Review

References (143)

1. Positional cloning of the mouse obese gene and its human homologue
2. Weight-reducing effects of the plasma protein encoded by the obese gene
3. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
4. Effects of the obese gene product on body weight regulation in ob/ob mice
5. Leptin, leptin receptors, and the control of body weight
6. Obesity and the regulation of energy balance
7. The effects of lesions in the hypothalamus in parabiotic rats
8. Obese, a new mutation in the house mouse
9. The role of leptin in human obesity and disease: A review of current evidence
10. Leptin regulation of neuroendocrine systems
11. Leptin
12. Leptin in reproduction
13. Leptin: Physiological actions
14. Obesity and insulin resistance
15. Effects of leptin on insulin sensitivity in normal rats
16. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat
17. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy
18. Modulation of insulin activities by leptin
19. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
20. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB)
21. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting GLUT4 translocation in L6 rat skeletal muscle cells
22. Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects
23. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
24. Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes
25. Acute hyperleptinemia does not modify insulin sensitivity in vivo in the rat
26. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo
27. Evidence against a direct effect of lepfin on glucose transport in skeletal muscle and adipocytes
28. Serum immunoreactiveleptin concentrations in normal-weight and obese humans
29. Familial partial lipodystrophy: A monogenic form of the insulin resistance syndrome
30. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
31. Leptin selectively decreases visceral adiposity and enhances insulin action
32. Acute stimulation of glucose metabolism in mice by leptin treatment
33. Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats
34. Differential effects of leptin in regulation of tissue glucose utilization in vivo
35. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: Reversal by insulin
36. Insulin regulation of leptin expression in streptozotocin diabetic pigs
37. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
38. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat
39. Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat
40. Leptin receptor missense mutation in the fatty Zucker rat
41. Intraventricular leptin reduces food intake and body weight of lean rats but not obese Zucker rats
42. Effects of intracerebroventricular infusion of leptin in obese Zucker rats
43. Effect of leptin on insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat
44. Fat (fat) and tubby (tub): Two autosomal recessive mutations causing obesity syndromes in the mouse
45. Evidence of altered hypothalamic pro-opiomelanocortin/neuropeptide Y mRNA expression in tubby mice
46. Low plasma leptin in response to dietary fat in diabetes- and obesityprone mice
47. Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats
48. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia
49. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats
50. Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in mice
51. The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes
52. Congenital leptin deficiency is associated with severe early-onset obesity in humans
53. A leptin missense mutation associated with hypogonadism and morbid obesity
54. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
55. Effects of recombinant leptin therapy in a child with congenital leptin deficiency
56. Partial leptin deficiency and human adiposity
57. Relatively low plasma leptin concentrations precede weight gain in Pima Indians
58. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
59. Leptin and the regulation of body weight in mammals
60. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
61. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
62. Molecular basis of partial lipodystrophy and prospects for therapy
63. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?
64. A cutaneous gene therapy approach to human leptin deficiencies: Correction of the murine ob/ob phenotype using leptin-targeted keratinocyte grafts
65. Mouse models of lipodystrophy
66. Lipoatrophy revisited
67. Life without white fat: A transgenic mouse
68. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
69. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
70. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice
71. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
72. A-ZIP/F-1 mice lacking white fat: A model for understanding lipoatrophic diabetes
73. Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30
74. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
75. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
76. Lilly lecture 1995. Glucose transport: Pivotal step in insulin action
77. Diabetes: The importance of the liver
78. Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice
79. Leptin receptor isoforms expressed in human adipose tissue
80. Leptin receptor action in hepatic cells
81. Insulin action and insulin resistance in human skeletal muscle
82. Fuel selection in human skeletal muscle in insulin resistance: A reexamination
83. Failure of leptin to affect basal and insulin-stimulated glucose metabolism of rat skeletal muscle in vitro
84. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells
85. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: Evidence for an effect of leptin on glucose uptake and decarboxylation
86. Acute and chronic effects of leptin on glucose utilization in lean mice
87. Leptin increases glucose transport and utilization in skeletal muscle in vitro
88. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: Evidence for a P13-kinase mediated effect
89. Leptin directly alters lipid partitioning in skeletal muscle
90. Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice
91. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
92. Insulin resistance in morbid obesity: Reversal with intramyocellular fat depletion
93. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes
94. Leptin does not affect adipocyte glucose metabolism: Studies in fresh and cultured adipocytes
95. Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes
96. Leptin stimulates uncoupling protein-2 mRNA expression and Krebs cycle activity and inhibits lipid synthesis in isolated rat white adipocytes
97. Regulation of fatty acid homeostasis in cells: Novel role of leptin
98. Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats
99. Does leptin contribute to diabetes caused by obesity?
100. Acute effects of leptin on glucose metabolism of in situ rat perfused livers and isolated hepatocytes
101. Acute effect of leptin on hepatic glycogenolysis and gluconeogenesis in perfused rat liver
102. Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes
103. 13C NMR study of the effects of leptin treatment on kinetics of hepatic intermediary metabolism
104. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action
105. The adipoinsular axis: Effects of leptin on pancreatic beta-cells
106. Leptin: A potent inhibitor of insulin secretion
107. Direct stimulation of basal insulin secretion by physiological concentrations of leptin in pancreatic beta cells
108. Leptin stimulates insulin secretion and synthesis in HIT-T 15 cells
109. Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells
110. Effects of leptin on insulin secretion from isolated rat pancreatic islets
111. Modulation of insulin secretion by leptin
112. Leptin suppression of insulin secretion and gene expression in human pancreatic islets: Implications for the development of adipogenic diabetes mellitus
113. Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1
114. Interaction of GLP-I and leptin at rat pancreatic B-cells: Effects on insulin secretion and signal transduction
115. Leptin affects pancreatic endocrine functions through the sympathetic nervous system
116. Fetal pancreatic islets express functional leptin receptors and leptin stimulates proliferation of fetal islet cells
117. Leptin receptors expressed on pancreatic beta-cells
118. Regulation of 86Rb+ outflow from pancreatic islets III. Possible significance of ATP
119. K+ channels: Generating excitement in pancreatic beta-cells
120. Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells)
121. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice
122. Failure of human and mouse leptin to affect insulin, glucagon and somatostatin secretion by the perfused rat pancreas at physiological glucose concentration
123. Do leptin receptors play a functional role in the endocrine pancreas?
124. How obesity causes diabetes in Zucker diabetic fatty rats
125. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
126. OB-Rb gene transfer to leptin-resistant islets reverses diabetogenic phenotype
127. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion
128. Leptin signalling
129. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line
130. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways
131. In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: Overlapping but distinct pathways from insulin
132. Effect of leptin on insulin signaling in rat-1 fibroblasts overexpressing HIR
133. Leptin inhibits insulin binding in isolated rat adipocytes
134. Insulin signal transduction and the IRS proteins
135. The role of PI 3-kinase in insulin action
136. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
137. Regulation of the Na,K-pump by leptin in 3T3-L1 fibroblasts
138. Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signaling pathways
139. Essential role of phosphoinositide 3-kinase in leptin-induced K(ATP) channel activation in the rat CRI-G1 insulinoma cell line
140. The role of SOCS-3 in leptin signaling and leptin resistance
141. SOCS-3 is an insulin-induced negative regulator of insulin signaling
142. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice
143. Insulin inhibits leptin receptor signalling in HEK293 cells at the level of janus kinase-2: A potential mechanism for hyperinsulinaemia-associated leptin resistance